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Abstract
Recent findings on the antioxidant effects of pretreatment with a-lipoic acid (a-LA) on the crush injury of rat scia-
tic nerve confirm the possible usefulness of a-LA administration in humans with peripheral nerve injuries. We dis-
cussed this issue in relation with our recent results in which the combined employment of a-LA and g-linolenic
acid with a rehabilitation program for six weeks reduced sensory symptoms and neuropathic pain in patients with
compressive radiculopathy syndrome from disc-nerve root conflict in comparison with patients submitted to
rehabilitation program alone for six weeks.
Dear Editors,
We read with great interest the paper: ‘’Intraperitoneal
alpha-lipoic acid to prevent neural damage after crush
injury to the rat sciatic nerve’’ by Senoglu and colleagues
published in the November issue 2009 of the Journal of
Brachial Plexus and Peripheral Nerve Injury [1]. We
congratulate the Journal for the interest in this topic.
This innovative study demonstrated the protective effect
of a-lipoic acid (a-LA) administration in rat sciatic
nerve crush injury by reducing the oxidative stress [1].
This paper has aroused our attention because these
findings can provide confirmation on the usefulness of
a-LA administration in humans in a very common
disease as back pain [2], which produces adverse effects
on activities of daily living. Back pain is a common and
disabling musculoskeletal disorder that often occurs in a
working-age population. Sciatic nerve injury is a com-
mon consequence of low back pain caused by lumbar
disc herniation that occurs with radicular pain, radiculo-
pathy, or both [3]. Nerve injury may depend on length
of time of crush insult. In fact, after the tissue destruc-
tion, free oxygen radicals can increase and cause tissue
damage [1]. Many patients are affected by sub-acute and
chronic low back pain and/or sciatica: this exerts an
important impact on the quality of life, causing interfer-
ence of sleep and enjoyment of life.
Many clinical studies have compared the efficacy of
surgery versus prolonged conservative treatment in the
low back pain and/or sciatica [4], concluding there is no
clear evidence that surgery is more beneficial than con-
servative treatment. Moreover often patients are affected
by neuropathic pain also after the surgery. It is common
knowledge that conservative treatments are tried first
and surgery must be the last resort, as drug therapy
(paracetamol, tramadol, nonsteroidal anti-inflammatory
drugs, myorelaxant, steroids, antidepressants, etc.) and
physical exercise (aerobic work, Back School, Mc Kenzie,
Global Postural Re-Education, etc.) can be efficacious in
the treatment of patients with back pain [4].
Recent studies showed that treatment with a-LA
reduced the pain, paresthesia, and numbness in sympto-
matic diabetic polyneuropathy [5], and in patients with
compressive radiculopathy syndrome from disc-nerve
root conflict [6]. The increase of oxidative stress could
be one of the causes of the nerve damage characteristic
of these types of neuropathy. A sequential pattern of
axonal degeneration and myelin degradation, followed
by rapid regeneration is the pathophysiological mechan-
ism into peripheral nerves after injury. It is known that
excessive free radical production, if not effectively
balanced by cellular antioxidant systems [superoxide dis-
mutase (SOD) and catalase (CAT)], is responsible for
aggression directed at phospholipids of membranes’
cells, mitochondrial, and cellular proteins. SOD is one
of protective systems against damage caused by free
radicals. SOD belongs to a family of metalloproteinases
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and it catalyzes the dismutation of the superoxide anion
radical to water and hydrogen peroxide, which is detoxi-
fied by the CAT activity [7].
a-LA is a powerful lipophilic antioxidant both in vitro
and in vivo [8]. It is known to act as scavenger of many
reactive oxygen species (ROS) and to interact with other
antioxidants such vitamin C and vitamin E, promoting
their regeneration. Therefore, a-LA has been proposed
as a treatment for oxidative disorders of the nervous
system characterized by an increase of free radicals.
Senoglu and colleagues, in their experimental model,
obtained an important neuroprotective effect measuring
the biochemical parameters (SOD, CAT activities, and
malondialdehyde) on oxidative stress after nerve injury
[1]. The activities of SOD and CAT were found to be
high in sciatic tissue of rats indicating high production
of superoxide anion radical. Therefore, the increase of
SOD and CAT activities may be a response against oxi-
dative stress. The results of Senoglu and colleagues cor-
related with our recent findings in which the combined
employment of a-LA and g-linolenic acid with a rehabi-
litation program for six weeks reduced sensory symp-
toms and neuropathic pain in patients with compressive
radiculopathy syndrome from disc-nerve root in com-
parison with patients submitted to rehabilitation pro-
gram alone for six weeks evaluating with Visual
Analogue Scale, Short Form (36) Health Survey, Oswes-
try Low Back Pain Disability Questionnaire, Aberdeen
Back Pain Scale, Revised Leeds Disability Questionnaire,
and Roland and Morris Disability Questionnaire [6].
Although the mechanisms of nerve damage are unclear,
it was hypothesized that both a-LA and SOD can
increase their antioxidant protective actions. In particu-
lar, SOD could prevent the formation of ROS [7], while
a-LA could act removing those just formed. Our data
suggested the importance of a-LA in the treatment of
peripheral nerve injuries, but further studies are needed
to explain the mechanisms of its neuroprotective effects
and before the use of a-LA in low back pain can be
instituted, as only in diabetic neuropathy and perhaps
chemotherapy-induced neuropathy has the usefulness of
a-LA been proved.
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